Hidden LRRK2 Overactivity Found in Parkinson’s Patients Without Known Mutations
A new study finds that about fourteen percent of Parkinson's patients without recognised pathogenic mutations show LRRK2 pathway activation as ...
A new study finds that about fourteen percent of Parkinson's patients without recognised pathogenic mutations show LRRK2 pathway activation as ...
A validated PacBio HiFi long-read sequencing workflow detects low-frequency mitochondrial DNA heteroplasmy with near-perfect accuracy and reveals dynamic variant trajectories ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.